
Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Est. Listeners
Insufficient chart data. Estimates will improve as the show charts.
- Per-Episode Audience
Est. listeners per new episode within ~30 days
N/A🎙 Daily cadence·66 episodes·Last published today - Monthly Reach
Unique listeners across all episodes (30 days)
N/A - Active Followers
Loyal subscribers who consistently listen
N/A
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 10 epsHosts
Not detected.
Recent guests
Recent episodes
AlphaNooner - The Themes Investors Can't Ignore Right Now with Dan Ahrens
Jun 24, 2026
50m 42s
AlphaNooner - The Cannabis M&A Wave Is Here with Sammy Armenia
Jun 22, 2026
36m 23s
#AlphaNooner - The Next Phase of Cannabis: Sam Brill on Growth, Competition, and Opportunity
May 29, 2026
35m 51s
AlphaNooner - Dr. Dana Lambert on Andira and the Future of Cannabinoid Healthcare
May 28, 2026
16m 49s
#AlphaNooner - Mid-Week Check-In: The Charts Worth Watching
May 27, 2026
25m 30s
Social Links & Contact
Official channels & resources
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 6/24/26 | ![]() AlphaNooner - The Themes Investors Can't Ignore Right Now with Dan Ahrens | Dan Ahrens joins the AlphaNooner to discuss the themes shaping markets right now, from cannabis uplistings and industry consolidation to psychedelic healthcare breakthroughs, AI infrastructure, industrials, and where capital is flowing. We'll explore what's changing beneath the surface, which trends may have staying power, and what investors should be watching in the second half of 2026. | 50m 42s | ||||||
| 6/22/26 | ![]() AlphaNooner - The Cannabis M&A Wave Is Here with Sammy Armenia | Sammy Armenia, VP of Corporate Development at C21 Investments, joins Mackenzie Peterson to discuss C21's planned transaction with Vireo Growth, why consolidation is accelerating across cannabis, and what the next generation of industry leaders may look like.Are we entering a new era where scale, capital access, and operational depth matter more than ever? Which markets are becoming most strategic? And could this be the start of a much larger M&A wave? | 36m 23s | ||||||
| 5/29/26 | ![]() #AlphaNooner - The Next Phase of Cannabis: Sam Brill on Growth, Competition, and Opportunity | No description provided. | 35m 51s | ||||||
| 5/28/26 | ![]() AlphaNooner - Dr. Dana Lambert on Andira and the Future of Cannabinoid Healthcare | No description provided. | 16m 49s | ||||||
| 5/27/26 | ![]() #AlphaNooner - Mid-Week Check-In: The Charts Worth Watching | No description provided. | 25m 30s | ||||||
| 5/26/26 | ![]() #AlphaNooner - The Market's Next Big Themes: Dan Ahrens on Where Investors Are Looking Now | No description provided. | 39m 43s | ||||||
| 5/22/26 | ![]() #AlphaNooner - Roundup Weekly: What Mattered in Markets | No description provided. | 56m 38s | ||||||
| 5/21/26 | ![]() #AlphaNooner - What Does Risk Management Mean in 2026? | No description provided. | 33m 10s | ||||||
| 5/20/26 | ![]() #AlphaNooner - Loren DeFalco on Cannabis Research and the Post-Rescheduling Market | No description provided. | 30m 56s | ||||||
| 5/19/26 | ![]() #AlphaNooner - Dan Ahrens on the Market's Most Important Themes Right Now | No description provided. | 37m 10s | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 5/18/26 | ![]() #AlphaNooner - Joe Saluzzi on HFT and the Evolution of Modern Markets | No description provided. | 44m 03s | ||||||
| 5/15/26 | ![]() #AlphaNooner - Rubicon Organics Earnings Special with Margaret Brodie | No description provided. | 24m 03s | ||||||
| 5/14/26 | ![]() #AlphaNooner - Eddy Elfenbein on Earnings, Inflation, and Stock Selection | No description provided. | 37m 08s | ||||||
| 5/13/26 | ![]() #AlphaNooner - Hirsh Jain on the Next Phase of Cannabis Investing | No description provided. | 42m 09s | ||||||
| 5/12/26 | ![]() #AlphaNooner - What Earnings Are Revealing About the Themes Leading This Market with Dan Ahrens | No description provided. | 50m 27s | ||||||
| 5/11/26 | ![]() #AlphaNooner - The Week Ahead in Markets | No description provided. | 22m 15s | ||||||
| 5/8/26 | ![]() #AlphaNooner - Buybacks and the Insider Edge: Minyi Chen on What Matters | No description provided. | 30m 48s | ||||||
| 5/7/26 | ![]() #AlphaNooner - $ATAI's Christian Angermayer on the Next Phase of Psychedelics in 2026 | No description provided. | 32m 34s | ||||||
| 5/6/26 | ![]() #AlphaNooner - Todd Harrison on the Next Phase of Cannabis Investing | No description provided. | 31m 49s | ||||||
| 5/5/26 | ![]() #AlphaNooner - Earnings and What's Driving Thematic Markets Now with Dan Ahrens | No description provided. | 40m 18s | ||||||
| 5/1/26 | ![]() #AlphaNooner - CEO Eric Offenberger on the Post-Rescheduling Playbook for Vext Science | No description provided. | 40m 02s | ||||||
| 4/30/26 | ![]() #AlphaNooner - Rubicon CEO on Premium Brands, UK, Cascadia Ramp $ROMJ $ROMJF | No description provided. | 33m 19s | ||||||
| 4/29/26 | ![]() #AlphaNooner - Rethinking Balanced Portfolios with CreativeOne's 21st Century Approach | No description provided. | 21m 50s | ||||||
| 4/28/26 | ![]() #AlphaNooner - Ibogaine in the Oval Office: Whiz Buckley on Healing Our Heroes | No description provided. | 38m 30s | ||||||
| 4/24/26 | ![]() #AlphaNooner - Noah Hamman on the Week That Changed Cannabis and Psychedelics | No description provided. | 52m 44s | ||||||
Showing 25 of 93
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.


